Fund Management At Engine No. 1 LLC Gilead Sciences, Inc. Transaction History

Fund Management At Engine No. 1 LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $116,677 - $127,297	1,578 Added 9.72%	17,818 $1.34 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $84,827 - $96,757	1,116 Added 7.38%	16,240 $1.25 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $101,739 - $115,913	1,316 Added 9.53%	15,124 $1.25 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $109,496 - $157,198	1,757 Added 14.58%	13,808 $1.19 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $36,498 - $41,690	-613 Reduced 4.84%	12,051 $743,000
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $117,979 - $132,880	2,044 Added 19.25%	12,664 $783,000
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $615,110 - $770,799	10,620 New	10,620 $631,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Fund Management At Engine No. 1 LLC, based on Form 13F filings with the SEC.

Stay updated on Fund Management At Engine No. 1 LLC with notifications on news.